Skip to main content
. 2020 Aug 19;14(5):817–827. doi: 10.1007/s12072-020-10069-3

Table 2.

Liver fibrosis evolution according to elastography

Control group (n = 74) Pirfenidone group (n = 122)
According to liver stiffness by hepatic elastography measurement
 Fibrosis progression profile (FPP) [n (%)] 13 (17.6%) 22 (18.3%)
 Fibrosis-stable profile (FSP) [n (%)] 58 (78.3%) 57 (46.7%)
 Fibrosis regression profile (FRP) [n (%)] 3 (4.1%) 43 (35.2%)

A significant decrease/increase in fibrosis was defined as 30% of change, compared to baseline values